Tags: 5 Best Stocks To Buy ,5 Best Stocks To Buy For July 2012 ,ARG ,CRIS ,DJCO ,PNSN ,SMA ,Top Stocks In 2012
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of prescription and over-the-counter generic drug producer Hi-Tech Pharmacal (Nasdaq: HITK ) are going downhill quickly today, losing as much as 21% following news of a competitor's drug being approved by the Food and Drug Administration.
So what: According to reports, Indian drug company Wockhardt today received FDA approval to market fluticasone, a corticosteroid used to treat allergic rhinitis and a generic version of GlaxoSmithKline's (NYSE: GSK ) Flonase. "What's the problem?" you might be wondering. Hi-Tech Pharmacal also markets a generic version of fluticasone in the United States. In fact, fluticasone accounted for $23 million of the company's $56.9 million in total revenue during the second quarter, so today's approval could indeed be pivotal.
Now what: The great thing about generic companies is that they have a seemingly endless supply of drugs falling off patent. Unfortunately, when you sometimes have multiple companies competing for the same bone, you run into an issue like Hi-Tech has today. It remains to be seen how badly Hi-Tech's revenue stream will! be affe cted by today's FDA ruling, but clearly this isn't good news and I completely understand the move lower. As of now I'm more than happy waiting this one out on the sidelines.
Craving more input? Start by adding Hi-Tech Pharmacal to your free and personalized watchlist so you can keep up on the latest news with the company.
Related Articles:5 Best Stocks To Buy For July 2012
Learning the Earnings Cycle
0 comments:
Post a Comment